FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029202877> ?p ?o ?g. }

• W2029202877 endingPage "1876" @default.
• W2029202877 startingPage "1876" @default.
• W2029202877 abstract "ABSTRACTObjective: identifying patients with chronic renal failure treated with hemodialysis therapy the prevalence of secondary hyperparathyroidism and observe if there is any relationship between treatment time and disease developmente. Method: this is about an exploratory and descriptive study from quantitative approach held in Nephron Clinical S/C Ltda, in Natal/RN. The project was approved by Ethics Committee of the Hospital Agamenon Magalhães in Recife/PE, under no protocol: 68/2008. The collection of clinical and laboratory data was performed by consulting the records of the dialysis unit available in electronic records. Results: Most patients (64.4%) were included in the age group up to 59 years, male (55.7%) with incomplete primary education 27.2% were married (53.8%). As regards the time of treatment, 60.3% of hemodialysis patients performed between 25 to 75 months. The main cause of chronic renal failure was hypertensive nephrosclerosis (39.3%), followed by glomerulonephritis (23.1%) and diabetes mellitus (18.5%). With respect of biochemical parameters, 34.7% of patients had Parathyroid hormone (PTH) and calcium phosphorus product above the target levels recommended by K / DOQI. Conclusion: there was a high prevalence of secondary hyperparathyroidism (56.1%) in patients according to levels of PTH. Descriptors: chronic renal insufficiency; hyperparathyroidism secondary; nursing.RESUMOObjetivo: identificar em pacientes com insuficiência renal crônica em terapia hemodialítica a prevalência de hiperparatireoidismo secundário e verificar se há relação entre o tempo de tratamento e o desenvolvimento da doença. Método: estudo exploratório, descritivo com abordagem quantitativa realizado na Nefron Clínica S/C LTDA, em Natal/RN. O projeto foi aprovado pelo Comitê de Ética em Pesquisa do Hospital Agamenon Magalhães em Recife – PE, sob o nº de protocolo: 68/2008. A coleta dos dados clínico-laboratoriais foi realizada mediante consulta aos registros da unidade de diálise disponíveis em prontuários eletrônicos. Resultados: a maioria dos pacientes estudados (64,4%) estavam compreendidos na faixa etária até 59 anos, do sexo masculino (55,7%), com ensino fundamental incompleto 27,2%, casados (53,8%). No que se refere ao tempo de tratamento, 60,3% dos pacientes realizavam hemodiálise entre 25 a 75 meses. A principal causa da IRC foi a nefroesclerose hipertensiva em 39,3% dos pacientes, seguida por glomerulonefrite (23,1%) e diabetes mellitus (18,5%). Com relação aos parâmetros bioquímicos, 34,7% dos pacientes apresentaram Paratormônio (PTH) e produto Cálcio fósforo acima dos níveis alvos recomendados pelo K/DOQI. Conclusão: Houve uma elevada prevalência de hiperparatireoidismo secundário (56,1%) nos pacientes estudados segundo níveis de PTH. Descritores: insuficiência renal crônica; hiperparatireoidismo secundário; enfermagem.RESUMEN Objetivo: identificar en los pacientes con insuficiencia renal crónica en tratamiento con hemodiálisis, la prevalencia de hiperparatiroidismo secundario y ver si hay alguna relación entre el tiempo de tratamiento y el desarrollo de la enfermedad. Metodo: estudio exploratorio, descriptivo y cuantitativo, celebrada en Nephron Clinical S / C Ltda, en Natal/RN. El proyecto fue aprobado por el Comité de Ética del Hospital de Magalhães Agamenón en Recife/PE, con protocolo: 68/2008. La recogida de datos clínicos y de laboratorio se realizó mediante la consulta de los registros de la unidad de diálisis disponibles en los registros electrónicos. Resultados: la mayoría de los pacientes (64,4%) se incluyeron en el grupo de edad hasta 59 años, varones (55,7%) con educación primaria incompleta 27,2% estaban casadas (53,8%). En cuanto al tiempo de tratamiento, el 60,3% de los pacientes de hemodiálisis se realiza entre 25 a 75 meses. La principal causa de IRC fue nefroesclerosis hipertensiva en el 39,3% de los pacientes, seguida de glomerulonefritis (23,1%) y la diabetes mellitus (18,5%). Con respecto a los parámetros bioquímicos, 34,7% de los pacientes tenían la hormona paratiroidea (PTH) y el producto de fósforo de calcio por encima de los niveles objetivo recomendado por K / DOQI. Conclusión: se observó una alta prevalencia de hiperparatiroidismo secundario (56,1%) en los pacientes de acuerdo a los niveles de PTH (56,1%) en los pacientes de acuerdo a los niveles de PTH. Descriptores: insuficiencia renal crónica; hiperparatiroidismo secundário; enfermería." @default.
• W2029202877 created "2016-06-24" @default.
• W2029202877 creator A5006248743 @default.
• W2029202877 creator A5045119111 @default.
• W2029202877 creator A5051904184 @default.
• W2029202877 creator A5082303913 @default.
• W2029202877 creator A5091258488 @default.
• W2029202877 date "2010-11-13" @default.
• W2029202877 modified "2023-09-29" @default.
• W2029202877 title "Hyperparathyroidism in patients with chronic renal failure treated in a private institution of Natal city, Brazil" @default.
• W2029202877 doi "https://doi.org/10.5205/reuol.1471-10047-1-le.0404spe201005" @default.
• W2029202877 hasPublicationYear "2010" @default.
• W2029202877 type Work @default.
• W2029202877 sameAs 2029202877 @default.
• W2029202877 citedByCount "0" @default.
• W2029202877 crossrefType "journal-article" @default.
• W2029202877 hasAuthorship W2029202877A5006248743 @default.
• W2029202877 hasAuthorship W2029202877A5045119111 @default.
• W2029202877 hasAuthorship W2029202877A5051904184 @default.
• W2029202877 hasAuthorship W2029202877A5082303913 @default.
• W2029202877 hasAuthorship W2029202877A5091258488 @default.
• W2029202877 hasBestOaLocation W20292028771 @default.
• W2029202877 hasConcept C126322002 @default.
• W2029202877 hasConcept C126894567 @default.
• W2029202877 hasConcept C2775945674 @default.
• W2029202877 hasConcept C2778063415 @default.
• W2029202877 hasConcept C2778653478 @default.
• W2029202877 hasConcept C2778838027 @default.
• W2029202877 hasConcept C2781208988 @default.
• W2029202877 hasConcept C29456083 @default.
• W2029202877 hasConcept C2993356106 @default.
• W2029202877 hasConcept C3018683220 @default.
• W2029202877 hasConcept C519063684 @default.
• W2029202877 hasConcept C71924100 @default.
• W2029202877 hasConceptScore W2029202877C126322002 @default.
• W2029202877 hasConceptScore W2029202877C126894567 @default.
• W2029202877 hasConceptScore W2029202877C2775945674 @default.
• W2029202877 hasConceptScore W2029202877C2778063415 @default.
• W2029202877 hasConceptScore W2029202877C2778653478 @default.
• W2029202877 hasConceptScore W2029202877C2778838027 @default.
• W2029202877 hasConceptScore W2029202877C2781208988 @default.
• W2029202877 hasConceptScore W2029202877C29456083 @default.
• W2029202877 hasConceptScore W2029202877C2993356106 @default.
• W2029202877 hasConceptScore W2029202877C3018683220 @default.
• W2029202877 hasConceptScore W2029202877C519063684 @default.
• W2029202877 hasConceptScore W2029202877C71924100 @default.
• W2029202877 hasIssue "4" @default.
• W2029202877 hasLocation W20292028771 @default.
• W2029202877 hasOpenAccess W2029202877 @default.
• W2029202877 hasPrimaryLocation W20292028771 @default.
• W2029202877 hasVolume "4" @default.
• W2029202877 isParatext "false" @default.
• W2029202877 isRetracted "false" @default.
• W2029202877 magId "2029202877" @default.
• W2029202877 workType "article" @default.